Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Black Diamond Therapeutics IncBDTX-1.900.001.42-0.63-63.09%-37.42%67.57$2.61$7.0012,334$2.455

Detail of Black Diamond Therapeutics Inc

 
CEO
Dr. Mark A. Velleca M.D., Ph.D.
Employees
54
Industry
Biotechnology
Sector
Healthcare
Market cap
$139M

Company details

Black Diamond Therapeutics, Inc., a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company's lead product candidate is BDTX-1535, a brain-penetrant epidermal growth factor receptor MasterKey inhibitor, which is in phase 2 clinical trial for the treatment of epidermal growth factor receptor mutant non-small cell lung cancer, as well as phase 1 clinical trial to treat glioblastoma. It is also developing BDTX-4933, a brain-penetrant RAF MasterKey inhibitor targeting KRAS, NRAS, and BRAF alterations in solid tumors that is in phase 1 clinical trial. In addition, the company is developing BDTX-4876, a MasterKey inhibitor of oncogenic FGFR2/3 mutations with selectivity versus FGFR1/4, which is in preclinical stage. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Black Diamond Therapeutics Inc
BDTX • XNGS • US
$2.455
-1.78 (-41.96%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$1.29
Margin profit
0.00%
52 week low
$1.915
52 week high
$7.39
50-day simple moving average
$2.50
200-day simple moving average
$2.61
Percent held by insiders
2.29%
Percent held by institutions
98.74%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
BDTX -43.43%
eps change
BDTX 0.00%